AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12192196 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine (5 to 10 mL of 1:10,000 epinephrine)
Number of subjects: 51
Study 12192196 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (4 mL)
Number of subjects: 51
Study 12192196 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine and Fibrin sealant
Number of subjects: 51
Study 9932950 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic room presentation
Number of subjects: 100
Study 9932950 — intervention group
Group type: COMPARATOR
Intervention: Conference room presentation
Number of subjects: 100
Study 9304384 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sialic acid level in blood
Number of subjects: 20
Study 9304384 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptoglobin level in blood
Number of subjects: 20
Study 9304384 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceruloplasmin level in blood
Number of subjects: 20
Study 2184993 — intervention group
Group type: COMPARATOR
Intervention: Lower-limb exercise training
Number of subjects: 28
Study 2184993 — intervention group
Group type: COMPARATOR
Intervention: Combined exercise training (upper-limb + lower-limb)
Number of subjects: 28
Study 2184993 — intervention group
Group type: COMPARATOR
Intervention: Upper-limb exercise training
Number of subjects: 28
Study 348228 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprapubic puncture site
Number of subjects: 98
Study 348228 — intervention group
Group type: COMPARATOR
Intervention: Nuchal puncture site
Number of subjects: 98
Study 31136247 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver operational competency and AAC system buy-in reported by parents and teachers
Number of subjects: 29
Study 31136247 — intervention group
Group type: EXPERIMENTAL
Intervention: AAC device use tracked via logging feature
Number of subjects: 29
Study 27875526 — intervention group
Group type: EXPERIMENTAL
Intervention: Caphosol (topically administered, rinsed orally four times daily from initiation of conditioning through day +20)
Number of subjects: 220
Study 27875526 — intervention group
Group type: COMPARATOR
Intervention: Placebo saline rinses (four times daily from initiation of conditioning through day +20)
Number of subjects: 220
Study 27875526 — intervention group
Group type: EXPERIMENTAL
Intervention: Caphosol
Number of subjects: 220
Study 27875526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 26553688 — intervention group
Group type: EXPERIMENTAL
Intervention: PsA‐TT (MenAfriVac) vaccine
Number of subjects: 360
Study 26553688 — intervention group
Group type: COMPARATOR
Intervention: Quadrivalent polysaccharide vaccine (PsACWY)
Number of subjects: 360
Study 23707040 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk odor
Number of subjects: 50
Study 23707040 — intervention group
Group type: COMPARATOR
Intervention: Formula milk odor
Number of subjects: 50
Study 21621834 — intervention group
Group type: EXPERIMENTAL
Intervention: NV1FGF at 0.2 mg/mL
Number of subjects: 525
Study 21621834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 525
Study 19615809 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovoil (Vitrolife, Kungsbacka, Sweden)
Number of subjects: 500
Study 19615809 — intervention group
Group type: COMPARATOR
Intervention: Mineral Oil (CryoBioSystem, L'Aigle, France)
Number of subjects: 500
Study 19615809 — intervention group
Group type: COMPARATOR
Intervention: Liquid Paraffin (Medicult, Lyon, France)
Number of subjects: 500
Study 17540966 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation therapy with investigational motor cortex stimulation
Number of subjects: 24
Study 17540966 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation therapy without investigational motor cortex stimulation
Number of subjects: 24
Study 15130570 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised acupuncture (up to 10 treatments)
Number of subjects: 148
Study 11811505 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix proteins (EMD)
Number of subjects: 12
Study 11811505 — intervention group
Group type: COMPARATOR
Intervention: Guided tissue regeneration (GTR) with bioabsorbable membranes
Number of subjects: 12
Study 9713783 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% dorzolamide three times daily
Number of subjects: 383
Study 9713783 — intervention group
Group type: COMPARATOR
Intervention: Placebo three times daily
Number of subjects: 383
Study 9713783 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% dorzolamide twice daily
Number of subjects: 383
Study 9713783 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily
Number of subjects: 383
Study 1483485 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinemet CR (200 mg levodopa/50 mg carbidopa)
Number of subjects: 8
Study 3902498 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 200 micrograms
Number of subjects: 12
Study 3902498 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 400 micrograms
Number of subjects: 12
Study 3902498 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 200 micrograms
Number of subjects: 12
Study 3902498 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oxitropium bromide (200 micrograms) and salbutamol (200 micrograms)
Number of subjects: 12
Study 30152245 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen-guided training (n=8)
Number of subjects: 18
Study 30152245 — intervention group
Group type: COMPARATOR
Intervention: Pain-based training (n=10)
Number of subjects: 18
Study 30152245 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 18
Study 30613073 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal vibration exercise (HVE)
Number of subjects: 28
Study 30613073 — intervention group
Group type: COMPARATOR
Intervention: Vertical vibration exercise (VVE)
Number of subjects: 28
Study 27084704 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG + Bifidobacterium BB-12 (LGG-BB12)
Number of subjects: 0
Study 27084704 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri RC-14 + Lactobacillus rhamnosus GR-1 (RC14-GR1)
Number of subjects: 0
Study 27084704 — intervention group
Group type: COMPARATOR
Intervention: RC14-GR1 + placebo
Number of subjects: 0
Study 27084704 — intervention group
Group type: COMPARATOR
Intervention: LGG-BB12 + placebo
Number of subjects: 0
Study 27084704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27084704 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (LGG-BB12 or RC14-GR1)
Number of subjects: 0
Study 25707826 — intervention group
Group type: EXPERIMENTAL
Intervention: Lingual fixed orthodontic appliances
Number of subjects: 52
Study 25707826 — intervention group
Group type: COMPARATOR
Intervention: Labial fixed orthodontic appliances
Number of subjects: 52
Study 22866909 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal natural progesterone, 200 mg daily from 22 to 34 weeks gestation
Number of subjects: 800
Study 22866909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study 19386947 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (25 mg) alone
Number of subjects: 14
Study 19386947 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (25 mg) with nitazoxanide (500 mg, twice daily for 6 days)
Number of subjects: 14
Study 19386947 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (25 mg) alone and Warfarin (25 mg) with nitazoxanide (500 mg, twice daily for 6 days)
Number of subjects: 14
Study 17697099 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized tests (Cognitive Drug Research)
Number of subjects: 81
Study 17697099 — intervention group
Group type: COMPARATOR
Intervention: Pencil-and-paper tests (Wechsler Adult Intelligence and Memory Scales)
Number of subjects: 81
Study 15681761 — intervention group
Group type: COMPARATOR
Intervention: Keyhole limpet hemocyanin (KLH) feeding on days 1 to 5 and 11 to 15, followed by subcutaneous immunization with KLH on day 26 and a booster on day 35.
Number of subjects: 46
Study 15681761 — intervention group
Group type: COMPARATOR
Intervention: Keyhole limpet hemocyanin (KLH) feeding and immunization protocol as described.
Number of subjects: 46
Study 15681761 — intervention group
Group type: COMPARATOR
Intervention: Analysis of genetic factors in tolerance induction.
Number of subjects: 46
Study 11587159 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril (2 mg oral for 12 weeks)
Number of subjects: 89
Study 11587159 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg oral for 12 weeks)
Number of subjects: 89
Study 11587159 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4-week period before randomization)
Number of subjects: 89
Study 9843101 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP (cyclophosphamide, doxorubicin, and cisplatin)
Number of subjects: 1526
Study 9843101 — intervention group
Group type: COMPARATOR
Intervention: Single-agent carboplatin
Number of subjects: 1526
Study 7604352 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated percutaneous lumbar discectomy (APLD)
Number of subjects: 0
Study 7604352 — intervention group
Group type: COMPARATOR
Intervention: Microdiscectomy
Number of subjects: 0
Study 2235228 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged maternal fluid supplementation (25% increase in fluids above baseline for 7 days)
Number of subjects: 19
Study 2235228 — intervention group
Group type: COMPARATOR
Intervention: Baseline fluid intake
Number of subjects: 19
Study 2235228 — intervention group
Group type: COMPARATOR
Intervention: Increased fluid intake
Number of subjects: 19
Study 391678 — intervention group
Group type: EXPERIMENTAL
Intervention: Essaven capsules (3 X 2 capsules per day)
Number of subjects: 34
Study 391678 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 31706140 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous progesterone
Number of subjects: 53
Study 31706140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 30851997 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-initiated PCR testing of respiratory specimens
Number of subjects: 181
Study 28290119 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide 400 mg/day
Number of subjects: 883
Study 28290119 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide 200 mg/day
Number of subjects: 883
Study 28290119 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine controlled-release monotherapy
Number of subjects: 883
Study 26096454 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible-tip catheter (Cool Flex™)
Number of subjects: 7
Study 26096454 — intervention group
Group type: COMPARATOR
Intervention: Rigid-tip catheter
Number of subjects: 7
Study 23343829 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lidocaine (1%)
Number of subjects: 11
Study 23343829 — intervention group
Group type: COMPARATOR
Intervention: Topical normal saline (0.9% NaCl)
Number of subjects: 11
Study 21786544 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (10,000 U/kg before skin incision, then 5000 U/kg at 1, 2, and 3 days post-operation)
Number of subjects: 160
Study 21786544 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 160
Study 19621695 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous hemihepatic inflow occlusion (HHO)
Number of subjects: 80
Study 19621695 — intervention group
Group type: COMPARATOR
Intervention: Intermittent total hepatic inflow occlusion (THO)
Number of subjects: 80
Study 16706573 — intervention group
Group type: EXPERIMENTAL
Intervention: epoetin alfa 40,000 units weekly
Number of subjects: 358
Study 16706573 — intervention group
Group type: COMPARATOR
Intervention: darbepoetin alfa 200 microg biweekly
Number of subjects: 358
Study 15807203 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus supplement (LB)
Number of subjects: 200
Study 15807203 — intervention group
Group type: COMPARATOR
Intervention: Fluid milk (L)
Number of subjects: 200
Study 11520329 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine (TGB) added to baseline Phenytoin (PHT)
Number of subjects: 0
Study 11520329 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) added to Phenytoin (PHT)
Number of subjects: 0
Study 11520329 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0
Study 8993240 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated ECC
Number of subjects: 60
Study 8993240 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 60
Study 8993240 — intervention group
Group type: COMPARATOR
Intervention: Uncoated ECC
Number of subjects: 60
Study 8115196 — intervention group
Group type: EXPERIMENTAL
Intervention: Active distraction technique (blowing out air during injection)
Number of subjects: 149
Study 8115196 — intervention group
Group type: COMPARATOR
Intervention: Control group (no distraction technique)
Number of subjects: 149
Study 3352906 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled‐release carbidopa/levodopa preparation
Number of subjects: 0
Study 3352906 — intervention group
Group type: COMPARATOR
Intervention: Standard Sinemet
Number of subjects: 0
Study 31859318 — intervention group
Group type: EXPERIMENTAL
Intervention: sbeIIa/b-AB pudding
Number of subjects: 10
Study 31859318 — intervention group
Group type: COMPARATOR
Intervention: WT control pudding
Number of subjects: 10
Study 30842490 — intervention group
Group type: EXPERIMENTAL
Intervention: Giant viruses (GVs) isolated from environmental samples using co-culture with Acanthomoeba castellanii
Number of subjects: 20
Study 30842490 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic characterization of isolated GVs
Number of subjects: 20
Study 27884690 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned pain modulation (CPM) using cold pressor pain for 2 minutes
Number of subjects: 2199
Study 27884690 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure pain thresholds (PPTs) recorded over the tibialis anterior muscle and upper trapezius muscle
Number of subjects: 2199
Study 27884690 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher level of education
Number of subjects: 2199
Study 27884690 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature withdrawal from the cold pressor test
Number of subjects: 2199
Study 27884690 — intervention group
Group type: EXPERIMENTAL
Intervention: High visual analog scale score
Number of subjects: 2199
Study 25454950 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked training schedule
Number of subjects: 36
Study 25454950 — intervention group
Group type: EXPERIMENTAL
Intervention: Random training schedule
Number of subjects: 36
Study 25454950 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 36
Study 23421331 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 457
Study 23421331 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 457
Study 21614842 — intervention group
Group type: EXPERIMENTAL
Intervention: TAKE (psychologically-informed training including physical activity, nutrition, and psychological issues)
Number of subjects: 0
Study 21614842 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal psychopathology
Number of subjects: 0
Study 19665260 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine gluconate
Number of subjects: 28
Study 19665260 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% isopropyl alcohol
Number of subjects: 28
Study 19665260 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% to 10% povidone‐iodine
Number of subjects: 28
Study 19665260 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol added to povidone‐iodine
Number of subjects: 28
Study 19665260 — intervention group
Group type: COMPARATOR
Intervention: Any of the preoperative skin‐ and nail‐preparation methods studied
Number of subjects: 28
Study 16942564 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy 300 IR (Group 3)
Number of subjects: 30
Study 16942564 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental doses up to 500 IR (Groups 1 and 2)
Number of subjects: 30
Study 16942564 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant dose of 500 IR (Group 4)
Number of subjects: 30
Study 16942564 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control group not explicitly mentioned)
Number of subjects: 30
Study 15283055 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous endometrial coculture (AECC)
Number of subjects: 1030
Study 15283055 — intervention group
Group type: COMPARATOR
Intervention: Previous IVF cycles (control)
Number of subjects: 1030
Study 11421834 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoxygenation with 4 deep breaths of 100% oxygen
Number of subjects: 100
Study 11421834 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoxygenation by breathing oxygen for 1, 3 or 5 min
Number of subjects: 100
Study 8986522 — intervention group
Group type: EXPERIMENTAL
Intervention: Binge eating group
Number of subjects: 0
Study 8986522 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 8491660 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise condition (audiotape recording of CCU nighttime sounds)
Number of subjects: 70
Study 8491660 — intervention group
Group type: COMPARATOR
Intervention: Control group (quiet, no audiotape recording)
Number of subjects: 70
Study 3760274 — intervention group
Group type: EXPERIMENTAL
Intervention: butyl methoxydibenzoylmethane + padimate O
Number of subjects: 5
Study 3760274 — intervention group
Group type: COMPARATOR
Intervention: vehicle + butyl methoxydibenzoylmethane
Number of subjects: 5
Study 3760274 — intervention group
Group type: COMPARATOR
Intervention: vehicle + butyl methoxydibenzoylmethane + padimate O
Number of subjects: 5
Study 3760274 — intervention group
Group type: COMPARATOR
Intervention: vehicle + padimate O
Number of subjects: 5
Study 3760274 — intervention group
Group type: COMPARATOR
Intervention: marketed sunscreen containing padimate O, oxybenzone, and octyl salicylate
Number of subjects: 5
Study 28325622 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic sea water
Number of subjects: 120
Study 28325622 — intervention group
Group type: COMPARATOR
Intervention: Buffered isotonic saline
Number of subjects: 120
Study 28325622 — intervention group
Group type: COMPARATOR
Intervention: Saline with xylitol
Number of subjects: 120
Study 28325622 — intervention group
Group type: COMPARATOR
Intervention: Tap water
Number of subjects: 120
Study 27487961 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg
Number of subjects: 200
Study 27487961 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg
Number of subjects: 200
Study 27487961 — intervention group
Group type: COMPARATOR
Intervention: Comparison of correlations at 120 minutes/day 1
Number of subjects: 200
Study 24332516 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream once daily for 6 weeks (superficial) or 12 weeks (nodular)
Number of subjects: 501
Study 24332516 — intervention group
Group type: COMPARATOR
Intervention: Surgical excision with a 4 mm margin
Number of subjects: 501
Study 24332516 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 501
Study 24332516 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious adverse events
Number of subjects: 501
Study 24332516 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal due to adverse events
Number of subjects: 501
Study 22209192 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Treatment (IT) group
Number of subjects: 103
Study 22209192 — intervention group
Group type: COMPARATOR
Intervention: Delayed Treatment (DT) group
Number of subjects: 103
Study 21712288 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral morphine (Oramorph)
Number of subjects: 39
Study 21712288 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oxycodone (Oxynorm)
Number of subjects: 39
Study 21712288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 18435186 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 - two-step total-etch adhesive (Single Bond, 3M) + resin composite (Supreme, 3M ESPE)
Number of subjects: 135
Study 18435186 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 - two-step self-etch adhesive (Clearfil SE, Kuraray) + resin composite
Number of subjects: 135
Study 18435186 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 - one-step self-etch adhesive (Xeno III, Dentsply) + resin composite
Number of subjects: 135
Study 18435186 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 teeth without occlusal loading)
Number of subjects: 135
Study 16567812 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin/dextrose infusion therapy
Number of subjects: 240
Study 14527014 — intervention group
Group type: COMPARATOR
Intervention: Subjects who do not exercise routinely
Number of subjects: 0
Study 14527014 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects who do exercise routinely
Number of subjects: 0
Study 10764173 — intervention group
Group type: EXPERIMENTAL
Intervention: Peroperative morphine titration (3 mg i.v. every 5 or 10 min until respiratory rate decreased)
Number of subjects: 40
Study 10764173 — intervention group
Group type: COMPARATOR
Intervention: Postoperative morphine administration in PACU
Number of subjects: 40
Study 10764173 — intervention group
Group type: EXPERIMENTAL
Intervention: Peroperative morphine titration
Number of subjects: 40
Study 8855488 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyloroplasty
Number of subjects: 30
Study 8855488 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyloromyotomy
Number of subjects: 30
Study 8855488 — intervention group
Group type: EXPERIMENTAL
Intervention: Pylorus stretching
Number of subjects: 30
Study 8855488 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 30
Study 1892076 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 99
Study 1892076 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 6619041 — intervention group
Group type: EXPERIMENTAL
Intervention: Mezlocillin (18 g/day)
Number of subjects: 0
Study 6619041 — intervention group
Group type: COMPARATOR
Intervention: Carbenicillin (18 g/day)
Number of subjects: 0
Study 6619041 — intervention group
Group type: EXPERIMENTAL
Intervention: Both antibiotics
Number of subjects: 0
Study 6619041 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbenicillin
Number of subjects: 0